Stockscreener 앱 받기
0.69%
시간 외 거래:
전일 마감가:
$710.82
열려 있는:
$710.87
하루 거래량:
412.58K
Relative Volume:
0.48
시가총액:
$89.40B
수익:
$359.05B
순이익/손실:
$3.30B
주가수익비율:
27.71
EPS:
25.83
순현금흐름:
$5.23B
1주 성능:
-1.58%
1개월 성능:
-0.53%
6개월 성능:
+20.25%
1년 성능:
+22.57%
1일 변동 폭
$707.16
$715.99
1주일 범위
$705.75
$728.37
52주 변동 폭
$464.42
$737.89
맥케슨 Stock (MCK) Company Profile
명칭
Mckesson Corporation
전화
972-446-4800
주소
6555 STATE HIGHWAY 161, IRVING, TX
MCK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
715.74 | 90.44B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
297.83 | 57.77B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
161.11 | 39.25B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
69.32 | 9.24B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.751 | 514.48M | 2.22M | -5.63M | -1.68M | -0.24 |
맥케슨 Stock (MCK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-04 | 재개 | Mizuho | Neutral |
| 2024-11-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | 재확인 | Leerink Partners | Outperform |
| 2024-08-08 | 재확인 | Mizuho | Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-07-06 | 다운그레이드 | Argus | Buy → Hold |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-02-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | 재확인 | Barclays | Overweight |
| 2021-11-02 | 재확인 | BofA Securities | Buy |
| 2021-11-02 | 재확인 | Evercore ISI | Outperform |
| 2021-11-02 | 재확인 | Jefferies | Buy |
| 2021-03-30 | 업그레이드 | Argus | Hold → Buy |
| 2020-11-02 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-08-04 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-05-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | 업그레이드 | UBS | Neutral → Buy |
| 2020-04-23 | 재개 | Credit Suisse | Neutral |
| 2020-03-18 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-08-05 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | 개시 | Guggenheim | Neutral |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2018-10-26 | 재확인 | Barclays | Equal Weight |
| 2018-07-20 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-03-08 | 개시 | Barclays | Equal Weight |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-02 | 재확인 | Mizuho | Neutral |
| 2018-01-24 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
맥케슨 주식(MCK)의 최신 뉴스
McKesson (MCK): Morgan Stanley Raises Price Target to $810 | MCK Stock News - GuruFocus
McKesson (MCK) Sees Price Target Boost from Morgan Stanley | MCK Stock News - GuruFocus
McKesson ideaShare Empowers Independent Pharmacies to Innovate and Thrive - Yahoo Finance
Mckesson CEO Tyler S. Brian sells $13.7m in stock By Investing.com - Investing.com India
Mckesson CEO Tyler S. Brian sells $13.7m in stock - Investing.com
Synergy (NASDAQ: SNYR) Strategic Partnership w/ McKesson - openPR.com
Conference Recap: McKesson ideaShare Showcases Power of Independent Pharmacies - Drug Topics
McKesson (MCK) Partners with Synergy CHC for Canadian Distributi - GuruFocus
Synergy CHC Corp. (NASDAQ: SNYR) Secures Retail Deals with McKesson Canada and Others as FOCUSfactor Expansion Surges Across North America - The Manila Times
FOCUSfactor Secures Massive Retail Expansion: McKesson Canada Deal Opens Thousands of New Locations - Stock Titan
Government Contract Update: $1B payment to MCKESSON CORPORATION - Quiver Quantitative
McKesson ideaShare 2025: Pharmacy of the Year Finalist Keri Bates Reflects on Teamwork, Community, and the Road Ahead - Pharmacy Times
Independent Pharmacies Face Mounting Challenges in Modern Health Care Landscape | McKesson ideaShare - Drug Topics
McKesson Corporation (MCK): If It Was Down, I’d Say “Fill Her Up,” Says Jim Cramer - MSN
McKesson's Commitment to Independent Community Pharmacies Takes Center Stage | McKesson ideaShare - Drug Topics
McKesson ideaShare 2025: Pharmacy Technicians Drive Efficiency and Care - Pharmacy Times
Expert Discusses McKesson's Approach to Supporting Community Pharmacies | McKesson ideaShare - Drug Topics
Evercore ISI Issues Positive Forecast for McKesson (NYSE:MCK) Stock Price - MarketBeat
How McKesson Ruling Will Inform Interpretations Of The TCPA - Law360
Financial Planning Remains Core Focus to Create Thriving Pharmacy Business | McKesson ideaShare - Drug Topics
Is McKesson Corporation (NYSE:MCK) Trading At A 34% Discount? - Yahoo Finance
Evercore ISI Adjusts Price Target on McKesson to $800 From $760, Maintains Outperform Rating - MarketScreener
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
McKesson stock hits all-time high, reaching $737.0 USD - Investing.com
Why Investors Shouldn't Be Surprised By McKesson Corporation's (NYSE:MCK) P/E - simplywall.st
Why McKesson (MCK) is a Top Value Stock for the Long-Term - Yahoo Finance
Here's Why McKesson (MCK) is a Strong Growth Stock - Yahoo Finance
McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Nimesh Jhaveri - McKesson
McLaughlin v. McKesson: Rebalancing the Scales Between Agency and Judicial Interpretation of the TCPA - Womble Bond Dickinson
Biologics by McKesson: Personalized Patient Care - McKesson
McKesson Newsroom: Latest Updates & Announcements - McKesson
Pharmaceutical Distribution & Solutions - McKesson
McKesson Supports Health System Pharmacy to Achieve More - McKesson
McKesson Business Solutions & GPO Strategies - McKesson
Maria N. Martinez - McKesson
Brian S. Tyler - McKesson
Calls of the Day: ServiceNow, S&P Global, McKesson Corp., Ross Stores, TJX and Burlington - CNBC
Atlas Specialty: Navigating Specialty Pharmacies - McKesson
W. Roy Dunbar - McKesson
McKesson's Impact: Safety, Preparedness & Opioids - McKesson
Mark Edwards - McKesson
Deborah Dunsire, M.D. - McKesson
Kathleen Wilson-Thompson - McKesson
Dave Ehlert - McKesson
Heather Easterling - McKesson
Joe DePinto, MBA - McKesson
Ginger Thorpe - McKesson
Oncology & Specialty Drug Distribution - McKesson
Francisco FragaExecutive Vice President, Chief Information Officer and Chief Technology Officer - McKesson
5 Ways McKesson is Globally Supporting COVID-19 Vaccination Efforts - McKesson
맥케슨 (MCK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
1.87%
자본화:
|
볼륨(24시간):